{
}
Morgan Stanley lowered its price target on Zoetis to $238, maintaining an "overweight" rating, while Piper Sandler raised theirs to $205. Various analysts have given mixed ratings, with an average target price of $215.90 and a majority rating the stock as a buy. Insider trading activity included the sale of 326 shares by EVP Roxanne Lagano, and Banco Santander increased its stake by 9.8%. Zoetis reported a quarterly EPS of $1.40, exceeding estimates, and announced a quarterly dividend of $0.50 per share.
BNP Paribas Exane has revised its price target for Zoetis Inc. to $219 from $232 while maintaining an outperform rating. Zoetis specializes in animal health products, with net sales primarily from companion animals (67.8%) and livestock (31.3%), and operates 22 production sites globally, with the U.S. contributing 54.8% of sales.
UBS has adjusted its price target on Zoetis Inc. to $189 from $193 while maintaining a neutral rating. The company focuses on animal health products, with net sales primarily from pets (64.4%) and livestock (34.5%), and operates 29 production sites globally, with the U.S. contributing 53.4% of sales.
UBS has adjusted its price target for Zoetis Inc. to $193 from $196 while maintaining a neutral rating. The company focuses on animal health products, with net sales primarily from pets (64.4%) and livestock (34.5%), and operates 29 production sites globally, with the U.S. contributing 53.4% of sales.
UBS has initiated coverage of Zoetis (ZTS) with a Neutral rating and a price target of $196. The firm highlights the company's strong position due to a multi-year innovation cycle, projecting a 6% revenue CAGR and 7% EBITDA CAGR from 2025-2030, while noting a balanced risk/reward profile amid concerns over slowing growth.
Trivant Custom Portfolio Group LLC increased its stake in Zoetis, owning 6,547 shares valued at $1,135,000 after acquiring 6,451 shares last quarter. Community Trust & Investment Co. also raised its position by 16.4%, now holding 106,129 shares worth $18,399,000. Institutional investors own 92.80% of Zoetis, which specializes in animal health products.
The livestock healthcare market is projected to grow from $50.74 billion in 2023 to $79.39 billion by 2028, driven by rising livestock populations, intensifying farming practices, and increasing awareness of zoonotic diseases. Key trends include technological innovations, biosecurity measures, and a focus on animal welfare. Major players in the market include Merck, Zoetis, and Bayer, among others, as they adapt to evolving disease landscapes and consumer demands.
Piper Sandler raised its target price on Zoetis from $195 to $210, maintaining an "overweight" rating, while Argus upgraded the stock to "strong-buy." With ten analysts rating it as a buy and a consensus target of $221.44, Zoetis reported a quarterly EPS of $1.58, exceeding estimates, and announced a dividend of $0.432 per share.
The Veterinary Healthcare For Livestock Animals market is poised for significant growth, driven by strategic collaborations, product innovations, and technological advancements among key players like Zoetis and Merck Animal Health. Comprehensive research highlights market dynamics, opportunities, and challenges across various regions, aiding stakeholders in informed decision-making. The report also details market segmentation by animal type, product type, and distribution channels, projecting trends up to 2032.
The global animal healthcare market is set to grow significantly, projected to reach USD 5,759.3 billion by 2032, driven by increased pet ownership, rising awareness of animal health, and technological advancements. Key trends include a shift towards organic solutions, personalized care, and sustainable products, alongside a surge in demand for veterinary services and livestock health. Major players are focusing on innovation and strategic partnerships to enhance their market presence.
Zoetis Inc.
Companies
The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
zoetis stock ratings updated as analysts adjust price targets and holdings
11:15 09.03.2025
bnp paribas exane lowers zoetis price target to 219 maintains outperform rating
14:39 27.02.2025
ubs lowers zoetis price target to 189 maintains neutral rating
15:09 14.02.2025
ubs lowers zoetis price target to 193 maintains neutral rating
14:56 10.02.2025
UBS Initiates Coverage of Zoetis with Neutral Rating and Price Target
15:43 10.12.2024
Zoetis Stock Sees Increased Institutional Investment and Positive Analyst Ratings
14:33 10.12.2024
livestock healthcare market poised for significant growth driven by disease prevention and technology
Alltech Inc.
Kemin Industries Inc.
IDEXX Laboratories Inc
Jurox Pty Ltd.
Ceva Santé Animale
Intas Pharmaceuticals Ltd.
Dechra Pharmaceuticals plc
Hester Biosciences Limited
Phytobiotics Futterzusatzstoffe GmbH
Merck & Co., Inc.
Elanco Animal Health Incorporated
Avivagen Inc.
Boehringer Ingelheim International GmbH
Vetoquinol SA
Bayer HealthCare AG
Huvepharma AD
Zoetis Inc.
Laboratorios Hipra S.A.
Vets Plus Inc.
Inovet (V.M.D. NV/sa)
Delacon Biotechnik GmbH
Virbac SA
Bimeda Holdings plc
Norbrook Laboratories Ltd.
BioChek BV
Neogen Corporation
Anpario plc
Alivira Animal Health Limited
The Archer-Daniels-Midland Company
Phibro Animal Health Corporation
Show more
06:28 04.12.2024
zoetis stock receives multiple upgrades and strong buy ratings from analysts
12:00 29.11.2024
veterinary healthcare for livestock animals market trends and growth opportunities forecast
Bayer Animal Health GmbH
IDEXX Laboratories, Inc.
Virbac SA
Vetoquinol S.A.
Boehringer Ingelheim Animal Health GmbH
Ceva Animal Health
Heska Corporation
Dechra Pharmaceuticals plc
Zoetis Inc.
MWI Veterinary Supply
Merck Animal Health
Elanco Animal Health Inc
USA
CAN
MEX
DEU
FRA
GBR
RUS
ITA
CHN
JPN
KOR
IND
BRA
ARG
COL
SAU
ARE
EGY
NGA
ZAF
Show more
08:59 29.11.2024
emerging trends shaping the future of animal healthcare market
United States Dollar
Boehringer Ingelheim International GmbH
Elanco Animal Health Incorporated
Merck & Co., Inc.
Virbac Group
Zoetis Inc.
Bayer AG
Abbott Laboratories
USA
DEU
Show more
20:01 27.11.2024
Trending
Subcategory
Industry Trends
Corporate News
Startups & Entrepreneurship
Global Trade Developments
Retail and Consumer Goods
Stock Market Updates
Supply Chain Management
Government Economic Policies
Fintech Startups
Industry Mergers & Acquisitions
Venture Capital Investments
Private Equity Deals
CEO Changes
AI Applications
Funding Rounds & Investments
Economic Indicators
Emerging Startups
Corporate Social Responsibility
AI Innovations
Market Analysis and Predictions
Countries:
Companies:
Apple Inc.
Grab2Go AS
Google Inc.
OLA ELECTRIC MOBILITY LTD
NVIDIA Corp
Amazon.com, Inc.
Microsoft Corporation
EFG Hermes Egypt
Broadcom Inc.
The Goldman Sachs Group, Inc.
XIAOMI-W
Tesla, Inc.
LG CNS
Delhivery Limited
Ecom Express Ltd.
Scripbox.COM India Ltd.
SK hynix Inc.
Tesmec S.p.A.
OpenAI ERC USD
FTSE NASDAQ Dubai UAE 20 Index
Currencies:
United States Dollar
Indian Rupee
Chinese Yuan
Euro
Japanese Yen
United Arab Emirates Dirham
South Korean Won
Pakistani Rupee
Egyptian Pound
Saudi Riyal
Brazilian Real
Qatari Riyal
Indonesian Rupiah
Vietnamese Đồng
Hong Kong Dollar
Offshore Chinese Yuan
Canadian Dollar
Malaysian Ringgit
People: